Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrew Kenneth McGregor, Deborah Moulton, Nick Bown, Gavin Cuthbert, David Bourn, Susanna Mathew, Raymond Dang, Philip Mounter & Gail Jones. (2016) Incidence and outcomes for adults diagnosed with acute myeloid leukemia in the north of England: a real world study. Leukemia & Lymphoma 57:7, pages 1575-1584.
Read now
Read now
Articles from other publishers (11)
Elizabeth Hubscher, Slaven Sikirica, Timothy Bell, Andrew Brown, Verna Welch, Alexander Russell-Smith & Paul D’Amico. (2021) Patterns of undertreatment among patients with acute myeloid leukemia (AML): considerations for patients eligible for non-intensive chemotherapy (NIC). Journal of Cancer Research and Clinical Oncology 147:11, pages 3359-3368.
Crossref
Crossref
Leonardo Assad Lomonaco, Rosalina J. Koifman & Carmen Freire. (2021) Perfil clínico-epidemiológico e sobrevida hospitalar dos casos de leucemia aguda em um hospital de referência em Rio Branco, Acre, 2007-2014. Cadernos Saúde Coletiva 29:3, pages 351-365.
Crossref
Crossref
Hailong Tang, Shuangshuang Jia, Lei Bi, Weijing Jia & Guangxun Gao. (2021) Treatment options for older unfit patients with acute myeloid leukemia. Future Oncology 17:7, pages 837-851.
Crossref
Crossref
Rebecca Crawford, Kate Sully, Rebecca Conroy, Chloe Johnson, Lynda Doward, Timothy Bell, Verna Welch, Francois Peloquin & Adam Gater. (2019) Patient-Centered Insights on Treatment Decision Making and Living with Acute Myeloid Leukemia and Other Hematologic Cancers. The Patient - Patient-Centered Outcomes Research 13:1, pages 83-102.
Crossref
Crossref
Amer M. Zeidan, Nikolai A. Podoltsev, Xiaoyi Wang, Jan Philipp Bewersdorf, Rory M. Shallis, Scott F. Huntington, Steven D. Gore, Amy J. Davidoff, Xiaomei Ma & Rong Wang. (2019) Temporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population‐level analysis. Cancer 125:23, pages 4241-4251.
Crossref
Crossref
Margaret Ann Perry. (2018) Acute myeloid leukaemia: A guide for practice nurses. Practice Nursing 29:3, pages 123-126.
Crossref
Crossref
R J van de Peppel, P A von dem Borne, S le Cessie & M G J de Boer. (2017) A new time-dependent approach for assessment of the impact of invasive aspergillosis shows effect on short- but not on long-term survival of patients with AML or high-risk MDS. Bone Marrow Transplantation 52:6, pages 883-888.
Crossref
Crossref
Esprit Ma, Vijayveer Bonthapally, Anita Chawla, Patrick Lefebvre, Ronan Swords, Marie-Hélène Lafeuille, Jonathan Fortier, Bruno Emond, Mei Sheng Duh & Bruce J. Dezube. (2016) An Evaluation of Treatment Patterns and Outcomes in Elderly Patients Newly Diagnosed With Acute Myeloid Leukemia: A Retrospective Analysis of Electronic Medical Records From US Community Oncology Practices. Clinical Lymphoma Myeloma and Leukemia 16:11, pages 625-636.e3.
Crossref
Crossref
H Bower, T M-L Andersson, M Björkholm, P W Dickman, P C Lambert & Å R Derolf. (2016) Continued improvement in survival of acute myeloid leukemia patients: an application of the loss in expectation of life. Blood Cancer Journal 6:2, pages e390-e390.
Crossref
Crossref
Neha Gupta, Austin Miller, Shipra Gandhi, Laurie A. Ford, Carlos E. Vigil, Elizabeth A. Griffiths, James E. Thompson, Meir Wetzler & Eunice S. Wang. (2015) Comparison of epigenetic versus standard induction chemotherapy for newly diagnosed acute myeloid leukemia patients ≥60 years old. American Journal of Hematology 90:7, pages 639-646.
Crossref
Crossref
S. V. Semochkin, T. N. Tolstykh, N. V. Arkhipova, V. L. Ivanova, O. V. Klyueva, V. V. Lunin, E. N. Misyurina, M. V. Tumanova & N. K. Khuazheva. (2015) Clinical and epidemiological characteristics of acute myeloid leukemias in adults according to the data of municipal hematology departments in Moscow. Terapevticheskii arkhiv 87:7, pages 26.
Crossref
Crossref